Lori Lyons-Williams
CIK 1693564 · Chief Commercial Officer · last filed 2026-03-05
Lori Lyons-Williams is a Chief Commercial Officer who has filed 19 SEC Form 4 insider transactions across 5 companies since 2017. Current disclosed insider exposure totals $171.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$171.1K
5
19
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 4,956 | $58.01 | $287.5K | $0 | 6 | 2026-02-02 |
| CTNM | Director | — | $11.88 | — | $0 | 2 | 2025-06-26 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 2 | 2021-04-19 |
| DERM | Chief Commercial Officer | 26,983 | $6.34 | $171.1K | $0 | 6 | 2019-08-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 1 | 2019-06-25 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-05 | — | Mixed | −4,956 | $0 | |
| 2026-02-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | +4,956 | $0 | EDGAR |
| 2025-06-26 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-10 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-19 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Disp (D) | — | $0 | EDGAR |